Skip to main content
BTC / USDTCRYPTO107,400+2.19%ETH / USDTCRYPTO3,840+2.13%SOL / USDTCRYPTO182.40−1.99%BNB / USDTCRYPTO652.30+0.66%XRP / USDTCRYPTO2.2150+1.61%DOGE / USDTCRYPTO0.3850−1.79%TON / USDTCRYPTO5.240+2.34%AVAX / USDTCRYPTO42.60−2.07%LINK / USDTCRYPTO22.40+2.28%ADA / USDTCRYPTO1.0520−1.68%TRX / USDTCRYPTO0.3300+0.92%DOT / USDTCRYPTO8.420+2.93%BTC / USDTCRYPTO107,400+2.19%ETH / USDTCRYPTO3,840+2.13%SOL / USDTCRYPTO182.40−1.99%BNB / USDTCRYPTO652.30+0.66%XRP / USDTCRYPTO2.2150+1.61%DOGE / USDTCRYPTO0.3850−1.79%TON / USDTCRYPTO5.240+2.34%AVAX / USDTCRYPTO42.60−2.07%LINK / USDTCRYPTO22.40+2.28%ADA / USDTCRYPTO1.0520−1.68%TRX / USDTCRYPTO0.3300+0.92%DOT / USDTCRYPTO8.420+2.93%
Preços
stocksJul 7, 2026, 1:42 PM

Vertex Pharmaceuticals (VRTX) Bullish Elliott Wave Targets $556.9–$646.4

An Elliott Wave analysis on Vertex Pharmaceuticals (VRTX) points to a bullish outlook with the next target range between $556.9 and $646.4.

VRTX

An Elliott Wave forecast for Vertex Pharmaceuticals (VRTX) indicates a bullish continuation, with the next price target zone set at $556.9 – $646.4.

Vertex is a biotechnology company developing treatments for serious diseases across multiple age groups, operating in the U.S., Europe, and internationally. The stock trades under the ticker VRTX in the Healthcare – Biotech sector.

The analysis suggests that the current wave structure supports further upside within the specified range.

Source: FXStreet Forex News